Have a personal or library account? Click to login
Development and Validation of Bioanalytical Method for Determination of Nebivolol and Valsartan in Human Plasma by Using RP-HPLC Cover

Development and Validation of Bioanalytical Method for Determination of Nebivolol and Valsartan in Human Plasma by Using RP-HPLC

By: R. N. Kachave and  A. G. Mundhe  
Open Access
|Mar 2022

References

  1. Neil O (2006) The Merck Index an encyclopedia of Chemical and Biological. 14th ed. Merck & Co. Inc1. 48: 379.
  2. Nadeem S, Asif H, Lakshita C, Shamsher A, Moloy M, Parminder SB (2011) Pharmacological and Pharmaceutical Profile of Valsartan: A Review. J. of Appl. Pharm. Sci. 01(04):12–19
  3. Goodman and Gilman's (2001) The Pharmacology Basis of Therapeutics. New York: Medical publishing Division, pp 249–260.
  4. Indian Pharmacopoeia (2010), Vol. III; Controller of Publication: New Delhi, 1759.
  5. Indian Pharmacopoeia (2010),, Vol. III; Controller of Publication: New Delhi, 2257.
  6. Pratapa P. Prasad, Ching-Ming Yeh, Peter Gurrieri, Robert Glazer, and James McLeod (2002) Pharmacokinetics of Multiple Doses of Valsartan in Patients with Heart Failure, Journal of cardiovascular pharmacology40:801–807
  7. Vaibhav rajoriya & Varsha kashaw (2017) RP-HPLC Method for the simultaneous estimation of Nebivolol hydrochloride & valsartan, analytical chemistry letters,7:4,520–530
  8. Shinde V, Sufiyan Ahmad, V.M Shastri, Yogesh Patil (2017) analytical method development and validation for the simultaneous estimation of Nebivolol and Valsartan by RP-HPLC in bulk and tablet dosage forms, Journal of pharmacy research 11:5:472–478
  9. Seetharaman R, Lakshmi KS (2014) Development and Validation of a Reverse Phase Ultra Performance Liquid Chromatographic Method for Simultaneous Estimation of Nebivolol and Valsartan in Pharmaceutical Capsule Formulation. J Chromatograph SeparatTechniq 5: 229. doi:10.4172/2157-7064.1000229
  10. NekkalaK, V Shanmukha KJ, Ramchandran D, Ganji R and Ganta S (2014) Method development and validation of stability indicating RP-HPLC method for simultaneous estimation of Nebivolol HCL and valsartan in bulk and its pharmaceutical formulations.Amer J of Adv Drug Del 2:.5:624–637
  11. Bhatia MS, Kokil SU(2009) Simultaneous estimation of Nebivolol HCL & valsartan using RP-HPLC in capsule dosage form, Ind. J of Pharm Sci71:.2:111–114
  12. Madhvi V, Siddhartha BK, Pratibhan C (2014) Simultaneous estimation of Nebivolol and Valsartan in tablet dosage form by RP-HPLC, Int J of Pharm and pharm Sci., 6:1:278–282
  13. Modiya JS, Pandya BC, Channabasavraj KP (2010) Simultaneous Estimation of Nebivolol Hydrochloride and Valsartan in Bulk and Capsule Dosage Form by Simultaneous Equation Method, Int J of ChemTech res 2:3:1387–1390.
  14. Sonawane LV, Poul BN, Usnale SV, Waghmare PV, Surwase LH (2014) Bioanalytical Method Validation and Its Pharmaceutical Application-A Review. Pharm Anal Acta 5: 288. DOI: 10.4172/2153-2435.1000288
  15. ICH guideline M10 on bioanalytical method validation, 13 March 2019, European medicine Agency EMA/CHMP/ICH/172948/2019. https://www.ema.europa.eu/en/ich-m10-bioanalytical-method-validation.
  16. Darkunde SL, Borhade RN (2017) Bioanalytical Method Validation: A Quality Assurance Auditor View Point. Asian J of Pharm Tech and Innov 5:59–60
  17. Tijare LK, Rangari NT, Mahajan UN (2016) A review on bioanalytical method development and validation. Asian J of PharmClin Res 9:6–10
  18. Method development and validation skills and tricks (2019) :3 (https://lubrizolcdmo.com/technical-briefs/analytical-method-development-and-validation/)
  19. Latha E, Sailaja B, Padmavati S (2014) Bioanalytical Method Development and Validation of by HPLC. J of Med and PharmInnov. 1:1–9
Language: English
Page range: 49 - 58
Submitted on: Apr 14, 2018
Accepted on: Jun 1, 2018
Published on: Mar 12, 2022
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Related subjects:

© 2022 R. N. Kachave, A. G. Mundhe, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.